米国の糖尿病治療装置市場の分析：Medtech 360

米国の糖尿病治療装置市場は、COVID-19パンデミックによる短期的な悪影響から力強い回復を見せており、今後数年でパンデミック前の成長動向を取り戻すと思われます。市場の成長を牽引するのは、ハイブリッド型・クローズドループのインスリンポンプやパッチポンプなどの新技術や革新的製品の導入です。これらの先端製品は高価格で取引され、予測期間中の市場の力強い成長に貢献すると予想されます。特に、CGM (連続血糖モニタリング) 装置分野は、CGMの医療費償還を受ける資格を得るための受給者の基準を緩和し、これらの機器への患者のアクセスを改善した、最近のCMSによるメディケアの適用範囲の更新に支えられて、予測期間中に急成長を遂げると思われます。

当レポートでは、米国の糖尿病治療装置の市場について分析し、全体的な市場動向の見通し (2019年～2032年) や、製品カテゴリー別の詳細動向、市場競争の状況、主な市場促進・抑制要因、昨今の主な動向などを調査しております。

目次

米国

概要

エグゼクティブサマリー

更新履歴

糖尿病治療装置市場

• 市場概要
• 市場の定義
• 市場予測データ
• 市場シェア
• 競合の考察
  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • Dexcom
  • Abbott Laboratories
  • Medtronic
  • その他の主要な競合企業
  • すべての競合企業に影響する要因
• 市場動向

血糖モニタリング装置市場

• 市場のハイライト
  • 主要なコンテンツの更新
• 市場の定義
• 市場予測データ
  • 血糖自己測定装置
  • 持続的血糖モニタリング (CGM) 装置
• 市場シェア
• 競合考察
  • 米国の血糖モニタリング装置市場：競合の考察
  • すべての競合企業に影響を与える要因

インスリン送達装置市場

• 市場のハイライト
• 市場の定義
• 市場予測データ
  • 頻回注射装置
  • インスリンポンプ
    • 従来型ポンプ・付属品
    • パッチポンプ
• 市場シェア
• 競合考察
  • 米国のインスリン送達装置市場：競合の考察
  • すべての競合企業に影響を与える要因

付録

調査手法

The US diabetes care device market has shown strong recovery from the short-term negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the coming years. Market growth will be driven by the introduction of new technologies and innovative products, such as hybrid closed-loop insulin pumps and patch pumps. These advanced products are anticipated to command higher prices and contribute to strong market growth over the forecast period. In particular, the CGM device segment will see rapid growth over the forecast period, supported by recent CMS updates to Medicare coverage that have relaxed the criteria for beneficiaries to qualify for CGM reimbursement, improving patient access to these devices.

This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in the US from 2019 through 2032.

The US diabetes care device market will grow strongly through 2032.

• How will growth vary between product segments?

• What are the factors driving market expansion?

CMS has recently expanded Medicare coverage for CGM devices.

• How will this expanded coverage impact the CGM device segment over the forecast period?

• Which competitors are going to benefit the most from the recent changes in CMS policy?

GLP-1 receptor agonists have been seeing growing adoption among the US patient population in recent years.

• How will adoption of GLP-1 receptor agonists affect the US diabetes care device market?

• Which market segments will be more impacted by the growing popularity of GLP-1 receptor agonists?

Numerous new competitors are expected to enter this space within the forecast period.

• Who are these competitors and what products are they bringing to the market?

• Which segments are seeing the most incoming competitors?

The insulin delivery device market is large and will continue to expand rapidly.

• What are new innovations are emerging in this segment?

• What factors are driving growth in this market?

• Which types of devices are seeing the strongest adoption, and how are these trends affecting other product segments?

Table of Contents

United States

Abstract

Executive Summary

• Market Highlights
• Competitive Highlights
• Market Developments
• Products Covered

Key Report Updates

Diabetes Care Device Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • Dexcom
  • Abbott Laboratories
  • Medtronic
  • Other Key Competitors
  • Factors Affecting All Competitors
• Market Developments

Glucose Monitoring Device Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • Self-Monitoring Blood Glucose Devices
  • Continuous Glucose Monitoring Devices
• Market Shares
• Competitive Insights
  • US Glucose Monitoring Device Market Competitive Insights
  • Factors Affecting All Competitors

Insulin Delivery Device Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • Multiple Daily Injection Devices
  • Insulin Pumps
    • Conventional Pumps and Accessories
    • Patch Pumps
• Market Shares
• Competitive Insights
  • US Insulin Delivery Device Market Competitive Insights
  • Factors Affecting All Competitors

Appendix

• Abbreviations
• Bibliography

Methodology

• Core Country Coverage Methodology
• Research Methodology
• Marketrack Methodology
• PriceTrack Methodology
• Forecast Methodology
• Supplemental Country Coverage Methodology
• Base-Year Ratio Analysis
• Market Forecasting

Tables and Figures

• Diabetes Care Device Market, by Product Type, US (USD), 2019-2032
• Diabetes Care Device Market Landscape, US (USD), 2022 and 2032
• Diabetes Care Device Market Leaders, by Product Type and Revenue, US, 2022
• Competitive Insights
• Companies Mentioned
• Recent Events in the Diabetes Care Device Market, US
• Emerging Products for the Diabetes Care Device Market, US
• Diabetes Care Devices Covered, US
• US Diabetes Care Device Market Drivers
• US Diabetes Care Device Market Limiters
• Diabetes Care Device Market, by Product Type, US (USD), 2019-2032
• Diagnosed Prevalent Drug-Treated Diabetes Patients, by Disease Type, US, 2019-2032
• Diabetes Care Device Market, by Product Type, US (USD), 2019-2032
• Diabetes Care Device Revenue Market Shares, US, 2022
• Diabetes Care Device Revenue Market Shares, by Product Type, US, 2022
• Novo Nordisk Competitive Insights
• Eli Lilly Competitive Insights
• Sanofi Competitive Insights
• Dexcom Competitive Insights
• Abbott Laboratories Competitive Insights
• Medtronic Competitive Insights
• Competitive Insights for Other Key Competitors
• Factors Affecting All Competitors
• Recent Events in the Diabetes Care Device Market, US
• Emerging Products for the Diabetes Care Device Market, US
• US Glucose Monitoring Device Market Drivers
• US Glucose Monitoring Device Market Limiters
• Glucose Monitoring Device Market, by Product Type, US (USD), 2019-2032
• Glucose Monitoring Device Market, by Product Type, US (USD), 2019-2032
• SMBG Device Market, by Product Type, US (USD), 2019-2032
• SMBG Device Market Growth, by Product Type, US, 2020-2032
• CGM Device Market, by Product Type, US (USD), 2019-2032
• CGM Device Market Growth, by Product Type, US, 2020-2032
• Glucose Monitoring Device Revenue Market Shares, US, 2022
• Glucose Monitoring Device Revenue Market Shares, by Product Type, US, 2022
• US Glucose Monitoring Device Market Competitive Insights
• Factors Affecting All Competitors
• US Insulin Delivery Device Market Drivers
• US Insulin Delivery Device Market Limiters
• Insulin Delivery Device Market, by Product Type, US (USD), 2019-2032
• Diagnosed Prevalent Diabetes Patients, by Treatment Type, US, 2019-2032
• Insulin Delivery Device Market, by Product Type, US (USD), 2019-2032
• MDI Device Market, by Product Type, US (USD), 2019-2032
• Insulin Syringe Market, US (USD), 2019-2032
• Insulin Pen and Accessory Market, by Product Type, US (USD), 2019-2032
• Insulin Pen and Accessory Market Growth, by Product Type, US, 2020-2032
• Insulin Pump Patients, by Product Type, US, 2019-2032
• Insulin Pump Market, by Product Type, US (USD), 2019-2032
• Conventional Pump Market, by Product Type, US (USD), 2019-2032
• Conventional Pump Market Growth, by Product Type, US, 2020-2032
• Patch Pump Market, by Product Type, US (USD), 2019-2032
• Patch Pump Market Growth, by Product Type, US, 2020-2032
• Insulin Delivery Device Revenue Market Shares, US, 2022
• Insulin Delivery Device Revenue Market Shares, by Product Type, US, 2022
• US Insulin Delivery Device Market Competitive Insights
• Factors Affecting All Competitors
• Abbreviations